Adherence to hepatitis b immunoglobulin (HBIG) after liver transplantation

Transplantation

Volumn 96, Issue 11, 2013, Pages

  Chang, Matthew S ^a   Stiles, Jessica B ^b   Lukose, Thresiamma S ^b   Balducci, Anastasia ^b   Brubaker, William D ^b   Burman, Blaire E ^c   Emond, Jean C ^b   Brown, Robert S ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Hospital Columbia University ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; NUCLEOTIDE DERIVATIVE; VIRUS DNA;

ADULT; ANTIGEN ANTIBODY REACTION; CAUCASIAN; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; END STAGE LIVER DISEASE; ETHNIC DIFFERENCE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

BIOLOGICAL MARKERS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HOME INFUSION THERAPY; HUMANS; IMMUNOGLOBULINS; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889830083     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000435696.23525.d0     Document Type: Letter

References (5)

1. Faria LC, Gigou M, Roque-Afonso AM, et al. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 2008; 134: 1890; quiz 2155.
2. Saab S, Yeganeh M, Nguyen K, et al. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation. Liver Transplant 2009; 15: 1525.
3. Wu CY, Chen YJ, Ho HJ, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012; 308: 1906.
4. Lenci I, Tisone G, Di Paolo D, et al. Safety of complete and sustained prophylaxis withdrawal in patients liver transplanted for HBV-related cirrhosis at low risk of HBV recurrence. J Hepatol 2011; 55: 587.
5. Saab S, Desai S, Tsaoi D, et al. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. Am J Transplant 2011; 11: 511.